Real-time Estimate
Cboe Europe
09:33:25 2024-07-03 am EDT
|
5-day change
|
1st Jan Change
|
653.5
CHF
|
-1.01%
|
|
-0.03%
|
+11.95%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
16,117
|
12,493
|
17,502
|
14,698
|
16,501
|
19,026
|
-
|
-
|
Enterprise Value (EV)
1 |
16,117
|
12,493
|
17,502
|
14,698
|
16,501
|
19,026
|
19,026
|
19,026
|
P/E ratio
|
13.3
x
|
12.6
x
|
14
x
|
9.98
x
|
15.8
x
|
16.3
x
|
15.1
x
|
14.5
x
|
Yield
|
4.12%
|
5.09%
|
4.47%
|
5.24%
|
5.65%
|
5.38%
|
5.8%
|
5.79%
|
Capitalization / Revenue
|
0.66
x
|
0.57
x
|
0.79
x
|
0.69
x
|
1.43
x
|
1.11
x
|
1.08
x
|
1.35
x
|
EV / Revenue
|
0.66
x
|
0.57
x
|
0.79
x
|
0.69
x
|
1.43
x
|
1.11
x
|
1.08
x
|
1.35
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
29.7
x
|
84.6
x
|
15.9
x
|
20.8
x
|
14.7
x
|
14.1
x
|
13.7
x
|
FCF Yield
|
-
|
3.37%
|
1.18%
|
6.3%
|
4.8%
|
6.79%
|
7.07%
|
7.3%
|
Price to Book
|
1
x
|
0.78
x
|
1.05
x
|
1.52
x
|
2.06
x
|
2.52
x
|
2.42
x
|
2.45
x
|
Nbr of stocks (in thousands)
|
33,176
|
30,293
|
31,309
|
30,826
|
28,256
|
28,819
|
-
|
-
|
Reference price
2 |
485.8
|
412.4
|
559.0
|
476.8
|
584.0
|
660.2
|
660.2
|
660.2
|
Announcement Date
|
2/28/20
|
3/2/21
|
3/1/22
|
3/2/23
|
4/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
24,320
|
21,728
|
22,219
|
21,358
|
11,541
|
17,195
|
17,575
|
14,125
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,651
|
1,472
|
1,783
|
2,054
|
1,497
|
1,626
|
1,711
|
1,760
|
Operating Margin
|
6.79%
|
6.77%
|
8.02%
|
9.62%
|
12.97%
|
9.46%
|
9.74%
|
12.46%
|
Earnings before Tax (EBT)
1 |
1,528
|
1,351
|
1,663
|
1,934
|
1,366
|
1,451
|
1,533
|
1,617
|
Net income
1 |
1,199
|
1,046
|
1,247
|
1,449
|
1,094
|
1,129
|
1,183
|
1,220
|
Net margin
|
4.93%
|
4.81%
|
5.61%
|
6.78%
|
9.48%
|
6.56%
|
6.73%
|
8.64%
|
EPS
2 |
36.48
|
32.78
|
39.93
|
47.76
|
37.01
|
40.52
|
43.86
|
45.49
|
Free Cash Flow
1 |
-
|
421
|
207
|
926
|
792
|
1,292
|
1,345
|
1,388
|
FCF margin
|
-
|
1.94%
|
0.93%
|
4.34%
|
6.86%
|
7.51%
|
7.65%
|
9.83%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
40.25%
|
16.6%
|
63.91%
|
72.39%
|
114.47%
|
113.66%
|
113.8%
|
Dividend per Share
2 |
20.00
|
21.00
|
25.00
|
25.00
|
33.00
|
35.54
|
38.28
|
38.20
|
Announcement Date
|
2/28/20
|
3/2/21
|
3/1/22
|
3/2/23
|
4/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2021 S1
|
2023 S1
|
---|
Net sales
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
|
821
|
780
|
889
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
814
|
-
|
Net income
1 |
-
|
537
|
618
|
619
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/28/20
|
8/13/20
|
8/17/21
|
9/7/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
421
|
207
|
926
|
792
|
1,292
|
1,345
|
1,388
|
ROE (net income / shareholders' equity)
|
7.66%
|
6.4%
|
11%
|
11.5%
|
12.7%
|
14.6%
|
13.7%
|
10.5%
|
ROA (Net income/ Total Assets)
|
0.54%
|
0.45%
|
0.52%
|
0.63%
|
0.51%
|
0.5%
|
0.5%
|
0.5%
|
Assets
1 |
220,526
|
232,962
|
238,889
|
230,000
|
213,422
|
225,728
|
236,668
|
243,942
|
Book Value Per Share
2 |
486.0
|
527.0
|
531.0
|
313.0
|
284.0
|
262.0
|
273.0
|
270.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
43
|
-
|
-
|
89
|
55
|
56
|
57
|
Capex / Sales
|
-
|
0.2%
|
-
|
-
|
0.77%
|
0.32%
|
0.32%
|
0.4%
|
Announcement Date
|
2/28/20
|
3/2/21
|
3/1/22
|
3/2/23
|
4/8/24
|
-
|
-
|
-
|
Last Close Price
660.2
CHF Average target price
630.1
CHF Spread / Average Target -4.56% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.05% | 21.05B | | +8.40% | 50.82B | | +5.91% | 49.81B | | +23.46% | 47.24B | | +14.31% | 42.57B | | +24.68% | 39.21B | | +19.39% | 33.69B | | -2.55% | 28.35B | | -9.35% | 27.07B | | +27.21% | 26.17B |
Other Life & Health Insurance
|